BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 497153)

  • 1. Purification of high-affinity Fab fragments from experimental autoimmune myasthenia gravis rabbits and their effect on isolated acetylcholine receptors.
    Mihovilovic M; Martinez-Carrion M
    Biochemistry; 1979 Oct; 18(21):4522-8. PubMed ID: 497153
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of acetylcholine receptor in diaphragms of rats with experimental autoimmune myasthenia gravis.
    Merlie JP; Heinemann S; Einarson B; Lindstrom JM
    J Biol Chem; 1979 Jul; 254(14):6328-32. PubMed ID: 447717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis: prototype of the antireceptor autoimmune diseases.
    Schönbeck S; Chrestel S; Hohlfeld R
    Int Rev Neurobiol; 1990; 32():175-200. PubMed ID: 1706686
    [No Abstract]   [Full Text] [Related]  

  • 6. [alpha-Bungarotoxin and acetylcholine receptor (author's transl)].
    Takamori M; Ishii N; Tsujihata M; Mori M; Kasai M
    No To Shinkei; 1977 Jun; 29(6):597-607. PubMed ID: 334200
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiological studies of thymectomized and nonthymectomized acetylcholine receptor-immunized animal models of myasthenia gravis.
    Niemi WD; Nastuk WL; Chang HW; Penn AS; Rosenberry TL
    Exp Neurol; 1979 Jan; 63(1):1-27. PubMed ID: 223859
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
    Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
    Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of anti-acetylcholine receptor Fab fragments from goats on functional membrane-bound receptor.
    Farach MC; Mihovilovic M; Paraschos A; Martinez-Carrion M
    Arch Biochem Biophys; 1982 Mar; 214(1):140-54. PubMed ID: 7081993
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of two different subpopulations of anti-acetylcholine receptor antibodies in a rabbit with experimental auto-immune myasthenia gravis.
    Zurn AD; Fulpius BW
    Eur J Immunol; 1977 Aug; 7(8):529-32. PubMed ID: 902680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of acetylcholine receptors in denervated muscle: interactions of receptors with immunoglobulin from patients with myasthenia gravis.
    Mittag TW; Tormay A; Massa T
    Mol Pharmacol; 1978 Jan; 14(1):60-8. PubMed ID: 625290
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune complexes in myasthenia gravis.
    Barkas T; Boyle RS; Behan PO
    J Clin Lab Immunol; 1981 Jan; 5(1):27-30. PubMed ID: 7218325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor.
    Vincent A; Newsom-Davis J
    Adv Cytopharmacol; 1979; 3():269-78. PubMed ID: 474297
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunochemical analysis of acetylcholine receptor and its relevance to specific treatment of experimental autoimmune myasthenia gravis.
    Fuchs S
    Adv Cytopharmacol; 1979; 3():279-85. PubMed ID: 382790
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of antibodies to Torpedo acetylcholine receptor on the acetylcholine receptor--ionic channel complex of Torpedo electroplax and rabbit intercostal muscle.
    Eldefrawi ME; Copio DS; Hudson CS; Rash J; Mansour NA; Eldefrawi AT; Albuguergue EX
    Exp Neurol; 1979 May; 64(2):428-44. PubMed ID: 428517
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenesis of myasthenia gravis as a disorder of acetylcholine receptors.
    Drachman DB; Pestronk A; Stanley EF
    Adv Cytopharmacol; 1979; 3():237-44. PubMed ID: 382787
    [No Abstract]   [Full Text] [Related]  

  • 17. Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.
    Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Jul; 41(1):13-8. PubMed ID: 6777100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acetylcholine receptors and myasthenia gravis].
    Yagi K; Uono M
    Nihon Rinsho; 1979; 37(8):3115-24. PubMed ID: 390183
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
    Vernet-der-Garabédian B; Morel E; Bach JF
    C R Acad Sci III; 1984; 298(16):449-56. PubMed ID: 6428718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.